Research Capital analyst Andre Uddin maintained his “Buy” rating and C$2.90 price target on Covalon Technologies (Covalon Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:COV) in a February 25 healthcare update, following what he characterized as a soft fiscal first quarter. Covalon reported Q1 fiscal 2026 revenue of $6.9-million for the period ended Dec. 31, […]
ATB Capital Markets analyst Martin Toner maintained a “Sector Perform” rating and C$210.00 price target on Kinaxis (Kinaxis Stock Quote, Chart, News, Analysts, Financials TSX:KXS) in a Feb. 25 equity research note, as he outlined key metrics to watch in the upcoming reporting cycle. Toner said that while AI infrastructure names have seen mixed performance […]
Share
Tweet
Share
